Henrik Lind • 1983 • Nesøya • 12 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
D DANZIG AS	Managing Director/CEO	382,197	989,056	100 % directly
H HCL AS	Managing Director/CEO	3,614,636	-111,870	100 % indirectly
N NORA MEDICAL AS	Managing Director/CEO	6,398,078	662,032	33.33 % indirectly
E EPSYK AS	Managing Director/CEO	5,735,864	752,711	23.75 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
D DANZIG AS	Chairman	382,197	989,056	100 % directly
H HCL AS	Chairman	3,614,636	-111,870	100 % indirectly
F FORTFRISK AS	Chairman	783,732	-230,486	50.03 % indirectly
N NOOB PHARMA AS	Chairman	2,000	-14,161	50 % indirectly
N NORA MEDICAL AS	Board Member	6,398,078	662,032	33.33 % indirectly
M MEDPOINT AS	Board Member	1,200	555,593	25 % indirectly
E EPSYK AS	Board Member	5,735,864	752,711	23.75 % indirectly
H HENRIK CHRISTER LIND	Holder	-	-	-

Last update: Apr 13, 2023

Related industries3

Wholesale and retail trade; repair of motor vehicles and motorcycles
Administrative and support service activities
Human health and social work activities

Direct relationships5

CL
Christer Torgilstveit Larsen1985
FORTFRISK AS, NORA MEDICAL AS, MEDPOINT AS, NOOB PHARMA AS, EPSYK AS
PA
Peder Anker1985
NORA MEDICAL AS, MEDPOINT AS, EPSYK AS
FG
Finn Gunnar Strekerud1964
EPSYK AS
MA
Maria Abrahamsen1992
EPSYK AS
LK
Lars Kristian Gullestad1985
MEDPOINT AS

Shares owned by Henrik Lind

Name	Share class	Total operating income	Total equity	Share
D DANZIG AS	Ordinære aksjer	382,197	989,056	100 % directly
H HCL AS		3,614,636	-111,870	100 % indirectly
F FORTFRISK AS		783,732	-230,486	50.03 % indirectly
N NOOB PHARMA AS		2,000	-14,161	50 % indirectly
N NORA MEDICAL AS		6,398,078	662,032	33.33 % indirectly
M MEDPOINT AS		1,200	555,593	25 % indirectly
E EPSYK AS		5,735,864	752,711	23.75 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024